- Oops!Something went wrong.Please try again later.
The White House unveiled the first phase of its national monkeypox vaccine strategy, with plans to send doses to areas with confirmed outbreaks.
The U.S. is releasing 56,000 doses of the Jynneos vaccine from the strategic national stockpile, and 240,000 doses will follow in the coming weeks.
HHS expects more than 750,000 doses to be made available over the summer. An additional 500,000 doses will undergo completion, inspection, and release throughout the fall, totaling 1.6 million doses available this year.
ACAM2000 carries a greater risk of certain serious side effects than Jynneos and cannot be provided to individuals who are immunocompromised or have heart disease.
Price Action: EBS shares closed at $31.25 on Tuesday.
Photo by Gerd Altmann from Pixabay
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.